Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 24 (HCG24, also called dJ1033B10.15) is a human gene located within the HLA region, which comprises genes involved in the immune system and antigen presentation. However, HCG24 is annotated as a non-protein coding gene and does not encode a protein product[2][4][6]. Unlike the classical HLA genes (e.g., HLA-A, HLA-B, HLA-C, HLA-DR, HLA-DQ, HLA-DP), which encode cell-surface receptors involved in immune recognition, HCG24 has no established function in antigen presentation, immune response, or disease and is not recognized as a therapeutic target[2][4][6]. HCG24 should not be confused with HLA receptors or proteins that are established drug targets[1][3][5]. If the intention was to query a protein-coding HLA gene or a known receptor, this entry would be incorrect for those purposes, as it is not a receptor or protein target.
None. No drugs target this molecule, so there is no mechanism of action characterized
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 24 (HCG24).